Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials
View ORCID ProfileAnton M. Sholukh, View ORCID ProfileAndrew Fiore-Gartland, Emily S. Ford, Yixuan J. Hou, Victor Tse, Hannah Kaiser, Arnold Park, Florian A. Lempp, Russell Saint Germain, Emily Bossard, Jia Jin Kee, Kurt Diem, Andrew B. Stuart, Peter B. Rupert, Chance Brock, Matthew Buerger, Margaret K. Doll, April Kaur Randhawa, Leonidas Stamatatos, Roland K. Strong, Colleen McLaughlin, Keith R. Jerome, Ralph S. Baric, David Montefiori, Lawrence Corey
doi: https://doi.org/10.1101/2020.12.07.20245431
Anton M. Sholukh
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
Andrew Fiore-Gartland
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
Emily S. Ford
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
3Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle WA
Yixuan J. Hou
5Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC
Victor Tse
5Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC
Hannah Kaiser
7Vir Biotechnology, San Francisco, CA
Arnold Park
7Vir Biotechnology, San Francisco, CA
Florian A. Lempp
7Vir Biotechnology, San Francisco, CA
Russell Saint Germain
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
Emily Bossard
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
Jia Jin Kee
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
Kurt Diem
4Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA
Andrew B. Stuart
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
Peter B. Rupert
2Basic Sciences Division, Fred Hutch Cancer Research Center, Seattle WA
Chance Brock
2Basic Sciences Division, Fred Hutch Cancer Research Center, Seattle WA
Matthew Buerger
2Basic Sciences Division, Fred Hutch Cancer Research Center, Seattle WA
Margaret K. Doll
10Department of Population Health Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY
April Kaur Randhawa
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
Leonidas Stamatatos
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
Roland K. Strong
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
2Basic Sciences Division, Fred Hutch Cancer Research Center, Seattle WA
Colleen McLaughlin
10Department of Population Health Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY
Keith R. Jerome
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
4Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA
Ralph S. Baric
5Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC
6Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
David Montefiori
8Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
9Department of Surgery, Duke University, Durham, NC
Lawrence Corey
1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
3Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle WA
4Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA
Article usage
Posted December 08, 2020.
Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials
Anton M. Sholukh, Andrew Fiore-Gartland, Emily S. Ford, Yixuan J. Hou, Victor Tse, Hannah Kaiser, Arnold Park, Florian A. Lempp, Russell Saint Germain, Emily Bossard, Jia Jin Kee, Kurt Diem, Andrew B. Stuart, Peter B. Rupert, Chance Brock, Matthew Buerger, Margaret K. Doll, April Kaur Randhawa, Leonidas Stamatatos, Roland K. Strong, Colleen McLaughlin, Keith R. Jerome, Ralph S. Baric, David Montefiori, Lawrence Corey
medRxiv 2020.12.07.20245431; doi: https://doi.org/10.1101/2020.12.07.20245431
Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials
Anton M. Sholukh, Andrew Fiore-Gartland, Emily S. Ford, Yixuan J. Hou, Victor Tse, Hannah Kaiser, Arnold Park, Florian A. Lempp, Russell Saint Germain, Emily Bossard, Jia Jin Kee, Kurt Diem, Andrew B. Stuart, Peter B. Rupert, Chance Brock, Matthew Buerger, Margaret K. Doll, April Kaur Randhawa, Leonidas Stamatatos, Roland K. Strong, Colleen McLaughlin, Keith R. Jerome, Ralph S. Baric, David Montefiori, Lawrence Corey
medRxiv 2020.12.07.20245431; doi: https://doi.org/10.1101/2020.12.07.20245431
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2944)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12749)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4586)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4358)
- Nursing (236)
- Nutrition (639)
- Oncology (2270)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6944)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)